Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT05982925

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders

Longitudinal Investigation of Cortical Demyelination and Meningeal Inflammation in Multiple Sclerosis and Related Disorders

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
170 (estimated)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

In this protocol, a combination of MRI, blood, and cerebrospinal fluid (CSF) analysis will be used to understand the natural history, underlying immunologic mechanisms, and clinical implications of central nervous system (CNS) lesions, in particular lesions in the cerebral cortex, in multiple sclerosis (MS) and other inflammatory and autoimmune disorders affecting the CNS. Patients with these disorders, as well as healthy controls, will undergo baseline clinical evaluation and testing, bloodwork, and MRI, with follow up clinical evaluation, bloodwork, and MRI at years 1, 3, and 6. Additional MRIs may be performed in patients with possible new lesion formation or to compare MRI techniques. Lumbar puncture will be performed on participants who are not currently being treated with disease modifying therapies and who are willing to undergo the procedure.

Conditions

Timeline

Start date
2022-05-06
Primary completion
2028-07-31
Completion
2034-07-31
First posted
2023-08-09
Last updated
2025-06-18

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05982925. Inclusion in this directory is not an endorsement.

Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders (NCT05982925) · Clinical Trials Directory